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Abstract
Background: Atrial septal defects (ASD) are the third most common type of congenital heart 
disease with an estimated incidence of 56 per 100,000 live births. Pulmonary Artery Hypertension 
(PAH) is one of thecomplication from ASD. Risk assessment in PAH can be determine by clinical 
patient, haemodynamic and exercise parameter. 6 Minute Walk Test (6MWT) is one of the 
exercise parameter risk assessment in PAH. The aim of this study is to know correlation of 6MWT 
with mean Pulmonary Arterial Pressure (mPAP)in adult patient with uncorrected ASD.). 6MWT  
is one of the exercise test that measures and integrated response of all systems responsible 
during exercise. Pulmonary arterial hypertension (PAH) is a problem encountered by patients 
with ASD. 6MWT is an objective tool to measure functional capacity of patients with PAH. 
Method: A cross sectional study was performed to determine the walking distance in patients 
with ASD. We studied 265 PAH in adult patient with uncorrected ASD at Sardjito Hospital, using 
the previous registry data (COHARD-PH (Congenital Heart Disease-Pulmonary Hypertension) 
registry). PAH were evaluated with right heart catheterization. 6MWT was collected. The 
correlation between 6MWT and MPAP was assessed by Spearman’s correlation analysis using 
SPSS. 
Result: We collected 265 patient PAH with uncorrected ASD (223 females (84%) and 42 males 
(16%), mean age 35.87 ± 12.6 years) underwent right heart catheterization. 31 (11,7%), 217 
(81,9%) and 17(6,4%) patients were in the low risk , intermediate and high risk for PAH according 
to 6MWT. 6MWT was correlated with mPAP (r = 0.374; P <0.001).
Conclusion: The mPAP was correlated with 6MWT in patient with uncorrected ASD. A 6MWT 
can be useful to measure risk assessment of PAH in patient with ASD. Most of our study 
population represent intermediate risk for PAH according to 6MWT.
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